 | Up a level |
Journal Article
Doz, F., Locatelli, F., Baruchel, A., Blin, N., De Moerloose, B., Frappaz, D., Dworzak, M., Fischer, M., Stary, J., Riemann, K., Taube, T. and Reinhardt, D. (2016). Phase I Study to Evaluate Dose, Safety and Tolerability of the Polo-Like Kinase Inhibitor Volasertib in Paediatric Patients with Acute Leukaemia and Advanced Solid Tumours. Pediatr. Blood Cancer, 63. S. S8 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Mertens, J., Stock, S., Luengen, M., von Berg, A., Kraemer, U., Filipiak-Pittroff, B., Heinrich, J., Koletzko, S., Gruebl, A., Wichmann, H. -E., Bauer, C. -P., Reinhardt, D., Berdel, D. and Gerber, A. (2010). IS PREVENTION OF ATOPIC DERMATITIS WITH HYDROLYSATE FORMULAS COST-EFFECTIVE? AN APPLICATION OF RESULTS OF THE GINI-STUDY TO THE GERMAN SITUATION. Pediatr. Res., 68. S. 66 - 68. NEW YORK: NATURE PUBLISHING GROUP. ISSN 0031-3998
Rossig, C., Juergens, H., Schrappe, M., Moericke, A., Henze, G., von Stackelberg, A., Reinhardt, D., Burkhardt, B., Woessmann, W., Zimmermann, M., Gadner, H., Mann, G., Schellong, G., Mauz-Koerholz, C., Dirksen, U., Bielack, S., Berthold, F., Graf, N., Rutkowski, S., Calaminus, G., Kaatsch, P. and Creutzig, U. (2013). Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria. Pediatr. Blood Cancer, 60 (10). S. 1574 - 1582. HOBOKEN: WILEY. ISSN 1545-5017
Waack, K., Wulff, B., Roellecke, K., Schneider, D., Paulussen, M., Zuzak, T., Laengler, A., Niehues, T., Brauer, N., Feddersen, I., Kontny, U., Calaminus, G., Dilloo, D., Irnich, M., Prokop, A., Graf, N., Hero, B., Fischer, M., Simon, T. and Reinhardt, D. (2017). Supra-Regional Study Sites to Improve the Pediatric Oncologic Patient Care and Recruitment into Early-Phase Clinical Trials: A German Model. Pediatr. Blood Cancer, 64. S. S346 - 2. HOBOKEN: WILEY. ISSN 1545-5017